BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 32886566)

  • 1. Health Department Efforts to Increase Hepatitis C RNA Testing Among People Appearing Out of Care: Comparison of Outreach Approaches, New York City, 2017.
    Webster R; Moore MS; Bocour A; Johnson N; Winters A
    Public Health Rep; 2020; 135(6):823-830. PubMed ID: 32886566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and Validation of Surveillance-Based Algorithms to Estimate Hepatitis C Treatment and Cure in New York City.
    Moore MS; Bocour A; Jordan L; McGibbon E; Varma JK; Winters A; Laraque F
    J Public Health Manag Pract; 2018; 24(6):526-532. PubMed ID: 29227418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Surveillance-Based Hepatitis C Care Cascade, New York City, 2017.
    Moore MS; Bocour A; Laraque F; Winters A
    Public Health Rep; 2018; 133(4):497-501. PubMed ID: 29902392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association Between Time to First RNA-Negative Test Result Among People With Hepatitis C Virus Infection and Homelessness or Testing at a Correctional or Substance Use Treatment Facility, New York City.
    Moore MS; Bocour A
    Public Health Rep; 2022; 137(6):1126-1135. PubMed ID: 34694921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Check Hep C: A Community-Based Approach to Hepatitis C Diagnosis and Linkage to Care in High-Risk Populations.
    Ford MM; Jordan AE; Johnson N; Rude E; Laraque F; Varma JK; Hagan H
    J Public Health Manag Pract; 2018; 24(1):41-48. PubMed ID: 28141668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized Clinical Trial of Inreach With or Without Mailed Outreach to Promote Hepatitis C Screening in a Difficult-to-Reach Patient Population.
    Desai N; Rich NE; Jain MK; Blackwell JM; Murphy CC; Perryman P; McBryde J; Quirk L; Clark C; Villarreal D; Waljee AK; Gopal P; Singal AG
    Am J Gastroenterol; 2021 May; 116(5):976-983. PubMed ID: 33337657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and mapping of hepatitis C infections among men who have sex with men in New York City.
    Tieu HV; Laeyendecker O; Nandi V; Rose R; Fernandez R; Lynch B; Hoover DR; Frye V; Koblin BA
    PLoS One; 2018; 13(7):e0200269. PubMed ID: 30020960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioral interventions to improve population health outreach for hepatitis C screening: randomized clinical trial.
    Mehta SJ; Day SC; Norris AH; Sung J; Reitz C; Wollack C; Snider CK; Shaw PA; Asch DA
    BMJ; 2021 May; 373():n1022. PubMed ID: 34006604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Get screened: a randomized trial of the incremental benefits of reminders, recall, and outreach on cancer screening.
    Fortuna RJ; Idris A; Winters P; Humiston SG; Scofield S; Hendren S; Ford P; Li SX; Fiscella K
    J Gen Intern Med; 2014 Jan; 29(1):90-7. PubMed ID: 24002626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deaths among people with hepatitis C in New York City, 2000-2011.
    Pinchoff J; Drobnik A; Bornschlegel K; Braunstein S; Chan C; Varma JK; Fuld J
    Clin Infect Dis; 2014 Apr; 58(8):1047-54. PubMed ID: 24523215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peer outreach point-of-care testing as a bridge to hepatitis C care for people who inject drugs in Toronto, Canada.
    Broad J; Mason K; Guyton M; Lettner B; Matelski J; Powis J
    Int J Drug Policy; 2020 Jun; 80():102755. PubMed ID: 32416538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Half a diagnosis: gap in confirming infection among hepatitis C antibody-positive patients.
    McGibbon E; Bornschlegel K; Balter S
    Am J Med; 2013 Aug; 126(8):718-22. PubMed ID: 23786667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors Associated With Opting Out of Automated Text and Telephone Messages Among Adult Members of an Integrated Health Care System.
    Steiner JF; Zeng C; Comer AC; Barrow JC; Langer JN; Steffen DA; Steiner CA
    JAMA Netw Open; 2021 Mar; 4(3):e213479. PubMed ID: 33769509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Test uptake and hepatitis C prevalence in 5483 Danish people in drug use treatment from 1996 to 2015: a registry-based cohort study.
    Øvrehus A; Nielsen S; Hansen JF; Holm DK; Christensen P
    Addiction; 2019 Mar; 114(3):494-503. PubMed ID: 30347471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C screening beyond CDC guidelines in an Egyptian immigrant community.
    Perumalswami PV; DeWolfe Miller F; Orabee H; Regab A; Adams M; Kapelusznik L; Aljibawi F; Pagano W; Tong V; Dieterich DT
    Liver Int; 2014 Feb; 34(2):253-8. PubMed ID: 23890188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engaging people who inject drugs in hepatitis C virus testing and prevention through community-based outreach, in Sydney, Australia.
    Coupland H; White B; Bates A; Park JN; Iversen J; Maher L
    Drug Alcohol Rev; 2019 Feb; 38(2):177-184. PubMed ID: 30652363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized Trial of Patient Outreach Approaches to De-implement Outdated Colonoscopy Surveillance Intervals.
    Lee JK; Koripella PC; Jensen CD; Merchant SA; Fox JM; Chang SX; Dang CH; Velayos FS; Boparai ES; Evans NS; Leung LJ; Badalov JM; Quesenberry CP; Corley DA; Levin TR
    Clin Gastroenterol Hepatol; 2024 Jun; 22(6):1315-1322.e7. PubMed ID: 38191014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C Virus (HCV) Care Continuum Outcomes and HCV Community Viral Loads Among Patients in an Opioid Treatment Program.
    Jordan AE; Cleland CM; Schackman BR; Wyka K; Perlman DC; Nash D
    J Infect Dis; 2020 Sep; 222(Suppl 5):S335-S345. PubMed ID: 32877560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Barriers to Treatment Among New York City Residents with Chronic Hepatitis C Virus Infection, 2014.
    King A; Bornschlegel K; Johnson N; Rude E; Laraque F
    Public Health Rep; 2016; 131(3):430-7. PubMed ID: 27252563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acceptability and preferences of point-of-care finger-stick whole-blood and venepuncture hepatitis C virus testing among people who inject drugs in Australia.
    Bajis S; Maher L; Treloar C; Hajarizadeh B; Lamoury FMJ; Mowat Y; Schulz M; Marshall AD; Cunningham EB; Cock V; Ezard N; Gorton C; Hayllar J; Smith J; Whelan M; Martinello M; Applegate TL; Dore GJ; Grebely J;
    Int J Drug Policy; 2018 Nov; 61():23-30. PubMed ID: 30388566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.